-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Fire Erupts Near MetLife Stadium After Jets-Bills Game
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
South Korea Launches Probe into NewJeans Contract Controversy
-
Met Office Issues Yellow Snow Warning for Nottinghamshire on Tuesday
-
UK Defence Secretary Warns Russia Nukes Not for Negotiation as HMS Vengeance Returns
-
Presidio Property Trust, Inc. Announces Earnings for the Quarter Ended September 30, 2026
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Spartan Capital Adds Institutional Investor, Upsizes Credit Facility to $100 Million
-
Diné Development Corporation Named 2026 Minority-Owned Business of the Year by Dayton Business Journal
-
Orlando Dreamers Announce Hundreds of Millions of Additional Financing Under Initial Letter of Intent
-
How to Remotely Access a PLC? Improve Maintenance Efficiency with InHand 4G/5G Industrial Routers
-
Graid Technology Extends VROC(TM) to AMD EPYC(TM) Platforms, Expanding Choice in Enterprise RAID
-
SMX Targets the Missing Link in Global Gold Markets: Proof
-
Lifeloc Reports Third Quarter 2026 Results
-
Sharecare Integrates IDMe into AskMD, Providing Over 100 Million Americans a Seamless, Secure Way to Access Personalized Health Guidance
-
Medical Care Technologies Inc. (OTCID:MDCE) Follows Q3 Profit Surge With Confirmed Software Development and Expanding Subsidiary Activity
-
NWPG's NFI Empire Reports Third Quarter 2026 Results
'Very ignorant rumour': Misinformation abounds about monkeypox
The recent emergence of hundreds of cases of monkeypox worldwide has already triggered a flood of misinformation online, much of it modelled on conspiracy theories that have been circulating since the start of the Covid-19 pandemic.
AFP Fact Check examined three claims that have arisen in the month since monkeypox cases began being recorded outside of areas in western and central Africa where it is endemic.
- Not a vaccine side effect -
Social media posts shared across the world have incorrectly claimed that the recent monkeypox cases are a "side effect" of the AstraZeneca Covid-19 vaccine.
The claim is linked to the fact that AstraZeneca's jab uses a chimpanzee adenovirus vector.
But health experts told AFP that this idea "has no basis in fact", in part because the viruses belong in different families -- poxvirus for monkeypox, and adenovirus for the Covid vaccine.
The vaccine "cannot generate new viruses inside humans and cause something like monkeypox," said Professor Eom Jung-shik, an infectious disease expert at the Gachon University Gil Medical Center.
The adenovirus is the vaccine vector, which means it is only a vehicle to transport genetic instructions to the body to trigger the production of a spike protein similar to that of the SARS-CoV-2 virus. This then prompts an immune response so the body can fight a real infection.
As in other viral vector vaccines, the chimpanzee adenovirus has been altered so it does not infect humans or replicate.
Professor Yoo Jin-hong, an epidemiologist at the Catholic University of Korea, said the AstraZeneca claim "appears to stem from the idea that chimpanzees are broadly referred to as monkeys, but this is a very ignorant rumour with no basis in fact".
Monkeypox was given its name because it was first discovered in a group of macaques in 1958 that were being studied for research purposes, but they are not the only animals that catch the disease.
Rodents are the most likely natural reservoir of monkeypox, according to the World Health Organization.
- Pfizer does not have a monkeypox vaccine -
Social media posts have also claimed that the US Food and Drug Administration (FDA) recently approved a new monkeypox vaccine from pharma giant Pfizer, which developed the first available Covid vaccine.
This is false; the only vaccine for the prevention of monkeypox in the United States was approved by the FDA in 2019, and Pfizer does not manufacture it.
Abby Capobianco, a press officer at the FDA, told AFP that the vaccine, called Jynneos, was "licensed by FDA for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox disease."
Jynneos is not a new vaccine -- the FDA approved it in September 2019.
Pharmaceutical company Bavarian Nordic, which produces Jynneos, announced on May 18, 2022 that the US government had placed a $119 million order for freeze-dried doses.
Jynneos is the only FDA-approved vaccine for monkeypox, however data has shown that a smallpox vaccine is 85 percent effective in preventing the disease, according to the US Centers for Disease Control and Prevention.
Pfizer told AFP that the company does not have a monkeypox vaccine.
- False Canada shingles claim -
Social media posts shared an image of a purported article from Canada's CTV News claiming that 95 percent of the monkeypox cases investigated by Canadian officials turned out to be shingles.
However Rob Duffy, CTV News manager of communications at its parent company Bell Media, told AFP that the network "never published such a story and that the screenshot does not show an authentic article from CTV News".
While some symptoms might be similar in cases of shingles and monkeypox, they are not caused by the same virus, according to Isaac Bogoch, professor at the Temerty Faculty of Medicine at the University of Toronto.
"There may be some overlap in their clinical presentation," but "monkeypox and shingles are two completely different infections," he told AFP.
O.Norris--AMWN